Maxillary sinusitis as a surrogate model for CF gene therapy clinical trials in patients with antrostomies

Abstract

CF sinusitis as a surrogate for lung disease is particularly well-suited for phase II clinical trials of gene transfer agents, with the potential for measuring clinical efficacy in relatively small numbers of patients over relatively short periods of time.